Ozempic is approved to treat type 2 diabetes Wegovy is specifically approved for chronic weight management In some cases, providers may prescribe Ozempic off-label for weight management when appropriate, but Wegovy is the formulation designed and approved for weight loss
At a seminar held in September 2024, experts from the National Academy of Neurology and the Forum on Nervous System Disorders discussed the current research findings and gaps in understanding the mechanisms of GLP-1RAs action in the brain
Treatment is typically limited to a maximum of 2 years
94% reduction in progression from pre diabetes to type 2 diabetes with tirzepatide.** **Based on a three-year clinical trial study (176-week treatment period) sponsored by Eli Lilly and Company, weekly injections of tirzepatide significantly reduced the risk of progression to type 2 diabetes by 94% in adults with prediabetes who were overweight or obese compared to placebo
Originally developed to help treat type 2 diabetes, GLP-1 drugs have proven effective at promoting weight loss , at least for as long as the medications remain in use
It can take eight weeks or longer to feel the full effects of GLP-1 drugs, including weight loss effects